Mandeep Singh Kumar, Shankha Banerjee join NATHEALTH leadership team
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security
Subscribe To Our Newsletter & Stay Updated